Talis Biomedical (TLIS) Insider Trading & Ownership $1.69 0.00 (0.00%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Talis Biomedical (NASDAQ:TLIS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage46.00%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$58,804.45Number OfInsiders Selling(Last 12 Months)0 Get TLIS Insider Trade Alerts Want to know when executives and insiders are buying or selling Talis Biomedical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TLIS Insider Buying and Selling by Quarter Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Talis Biomedical Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/3/2024Braden Michael LeonardMajor ShareholderBuy500$4.00$2,000.00 8/30/2024Braden Michael LeonardMajor ShareholderBuy151$4.25$641.75 8/28/2024Braden Michael LeonardMajor ShareholderBuy1,215$3.96$4,811.40 8/26/2024Braden Michael LeonardMajor ShareholderBuy13,167$3.90$51,351.30 (Data available from 1/1/2013 forward) TLIS Insider Trading Activity - Frequently Asked Questions Who is on Talis Biomedical's Insider Roster? The list of insiders at Talis Biomedical includes Braden Michael Leonard. Learn more on insiders at TLIS. What percentage of Talis Biomedical stock is owned by insiders? 46.00% of Talis Biomedical stock is owned by insiders. Learn more on TLIS's insider holdings. Which Talis Biomedical insiders have been buying company stock? The following insider purchased TLIS shares in the last 24 months: Braden Michael Leonard ($58,804.45). How much insider buying is happening at Talis Biomedical? Insiders have purchased a total of 15,033 TLIS shares in the last 24 months for a total of $58,804.45 bought. Talis Biomedical Key ExecutivesMr. Robert Kelley MBA (Age 52)CEO & Director Compensation: $852.36kDr. Andrew A. Lukowiak Ph.D. (Age 51)President & Chief Scientific Officer Compensation: $904.9kDr. Rustem F. Ismagilov Ph.D. (Age 50)Co-Founder & Director Compensation: $53.95kMs. Rebecca Markovich (Age 50)Interim Chief Financial Officer Compensation: $379.23kMr. Liang Li Ph.D.Co-Founder and Director of Technology & StrategyMs. Emily FaucetteSenior Vice President of Corporate Communications & Investor RelationsMs. Jill GreenSenior Vice President of LegalMr. Matthew PepeVice President of Human ResourceMs. Margaret Barrett M.S.ControllerGillian GreenCompany Secretary More Insider Trading Tools from MarketBeat Related Companies Cue Health Insider Transactions Precipio Insider Transactions Spectaire Insider Transactions ThermoGenesis Insider Transactions Lucid Diagnostics Insider Transactions Biodesix Insider Transactions Sera Prognostics Insider Transactions QuidelOrtho Insider Transactions Quest Diagnostics Insider Transactions Laboratory Co. of America Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:TLIS) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talis Biomedical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talis Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
